Similar articles

• [Lung cancer].

  Komagata H, Yoneda S. Komagata H, et al. Gan To Kagaku Ryoho. 2004 Oct;31(10):1609-13. Gan To Kagaku Ryoho. 2004. PMID: 15508459 Review. Japanese.
• [Tumor markers in lung cancer].

  Niho S, Shinkai T. Niho S, et al. Gan To Kagaku Ryoho. 2001 Dec;28(13):2089-93. Gan To Kagaku Ryoho. 2001. PMID: 11791391 Review. Japanese.
• Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.

  Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E. Foa P, et al. Anticancer Res. 1999 Jul-Aug;19(4C):3613-8. Anticancer Res. 1999. PMID: 10629660
• Tumor markers in patients with chronic renal failure.

  Filella X, Cases A, Molina R, Jo J, Bedini JL, Revert L, Ballesta AM. Filella X, et al. Int J Biol Markers. 1990 Apr-Jun;5(2):85-8. Int J Biol Markers. 1990. PMID: 1704405
• Value of tumour and inflammatory markers in lung cancer.

  Oremek GM, Sauer-Eppel H, Bruzdziak TH. Oremek GM, et al. Anticancer Res. 2007 Jul-Aug;27(4A):1911-5. Anticancer Res. 2007. PMID: 17649794